AusPAR: Polatuzumab vedotin

Australian Public Assessment Report

AusPAR

AusPAR: Polatuzumab vedotin [PDF, 358.27 KB]

AusPAR: Polatuzumab vedotin [Word, 488.03 KB]

Attachment: Product Information for Polatuzumab vedotin [PDF, 171.04 KB]

Attachment: Product Information for Polatuzumab vedotin [Word, 80.19 KB]

Device/Product Name

Polivy

Active ingredients

Polatuzumab vedotin

AusPAR Date

3 December 2019

Published

2 January 2020

Submission Number

PM-2019-00471-1-6

Submission Type

New biological entity

Decision

Approved